openPR Logo
Press release

Metagenomic Sequencing : Obtain PDF Sample

05-05-2025 07:58 PM CET | Health & Medicine

Press release from: The Insight Partners

The Metagenomic Sequencing Market is expected to register a CAGR of 17.3% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

Metagenomic Sequencing for Diagnostics: The increasing use of metagenomic sequencing to diagnose complex microbial communities is driving personalized medicine and improving patient care. Advances in genomic technology are key market drivers, with collaborations between leaders and health institutions. SWOT analysis indicates strong growth potential, though cost concerns remain.

Get Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006697/?utm_source=OpenPR&utm_medium=10309

Market leaders and key company profiles

Illumina, Inc.
Thermo Fisher Scientific, Inc.
QIAGEN N.V.
PerkinElmer
Oxford Nanopore Technologies Ltd.
BGI Group
Macrogen Inc.
GENEWIZ
Eurofins Scientific

Contact Us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metagenomic Sequencing : Obtain PDF Sample here

News-ID: 4000006 • Views:

More Releases from The Insight Partners

Modular Power Plants Regional Data And Revenue Analysis
Modular power plants are innovative energy solutions designed for quick deployment, scalability, and flexibility. Unlike traditional large-scale facilities, they consist of pre-engineered modules that can be transported and assembled on-site, reducing construction time and costs. These plants are widely used in remote areas, industrial projects, and emergency power needs, providing reliable electricity where grid access is limited. They can operate on diverse energy sources, including natural gas, diesel, renewables, and
Whole Exome Sequencing - Obtain Ultimate PDF Guide
Whole exome sequencing is the next-generation technique that is widely preferred as a substitute for whole genome sequencing due to its advantages. As the whole sequencing technique reduces the time and cost of analyzing genetics, it also offers a reduction of time spent in the trial and error for the drug formulation. The next-generation sequencing has enabled higher results of the analysis for genotypic and phenotypic relations among the human
Neurophotonics Market Analysis, Size, Share, Growth Drivers, and Trends 2031
The Global Neurophotonics Market 2031 that centers around Neurophotonics Market examines the significant components with a top to bottom methodology and empowers the client to survey the drawn-out based interest additionally predicts explicit executions. This report gives subjective investigation, clarifying item scope and expounding Market experiences and standpoint. To Get Sample Copy of Report, Click Here - https://www.theinsightpartners.com/sample/TIPRE00040006/?utm_source=OpenPR&utm_medium=10607 (Our SAMPLE COPY of the report offers a quick advent to
Dacarbazine Market Gains Momentum with Strategic Acquisitions
Dacarbazine Market Gains Momentum with Strategic Acquisitions
New York, US - September 05, 2025 - The Insight Partners today announced the publication of its latest Dacarbazine Market report titled "Dacarbazine Market Share, Size, Trends, and Forecast by 2031," which anticipates steady expansion in the global oncology pharmaceutical market. The report sheds light on how ongoing cancer research, biosimilar development, and strategic manufacturing initiatives are significantly influencing the Dacarbazine Market size and driving competitive Dacarbazine Market share among

All 5 Releases


More Releases for Metagenomic

Metagenomic Sequencing Market Global Rising Demand & Huge Scope Till 2032
The Metagenomic Sequencing Market was valued at approximately USD 0.58 billion in 2023 and is projected to reach around USD 2.08 billion by 2032, reflecting a compound annual growth rate (CAGR) of 15.00% from 2024 to 2032. Metagenomic Sequencing Market Overview The Metagenomic Sequencing Market is experiencing significant growth, driven by advancements in sequencing technologies and increasing applications in microbiome research, disease diagnostics, and environmental studies. This technology enables the
Rising Prevalence Of Infectious Diseases Fuels Growth In The Metagenomic Sequenc …
What Are the Projected Growth and Market Size Trends for the Metagenomic Sequencing Market? There has been a swift expansion of the metagenomic sequencing market in the past few years. Its value is projected to rise from $2.13 billion in 2024 to $2.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.5%. The considerable growth seen historically is due to factors such as the increased involvement of
Metagenomic Sequencing Market Key Trends and Forecast to 2033
The latest report Metagenomic Sequencing Market Share, Size, Growth, Opportunities, and Forecast 2025-2033" by Market Insights delivers a thorough analysis of the industry, encompassing market insights. It also covers competitor and regional analysis, along with recent advancements in the market. crucial factors boosting demand include a lesser focus on enhancing the seeker experience, managing large aspirant pools effectively, and using data analytics to optimize reclamation strategies. The report presents a
Metagenomic Sequencing Market to Observe Fastest Growth in Asia-Pacific
The metagenomic sequencing market was USD 1,938 million in 2022, and it will reach USD 6,899 million, advancing at a 17.20% compound annual growth rate, by 2030. The growth in the industry is because of the decreasing cost of this technique. Furthermore, the implementation of this technique is increasing in agricultural biotechnology, where it allows the analysis of the whole genome in an environmental sample without the need for culturing. Request
Metagenomic Sequencing Market Growth Status, Regional Trends Forecast To 2028
According to Precision Business Insights (PBI), the latest report, the Metagenomic Sequencing Market is expected to be valued at USD 1,126.2 million in 2022, growing at an 17.9% CAGR from 2022 to 2028. The primary driver of the expansion of the global Metagenomic Sequencing market is growing awareness of genetic disorders and the availability of advanced technological platforms. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/metagenomic-sequencing-market/
Metagenomic Sequencing Market: Industry Size, Demand & Top Market Players 2024
The “Global Metagenomic Sequencing Market Set For Modest Growth, To Reach Around USD 30.62 Million by 2025” report has been added to Zion Market Research offering. (Sample Copy Here) The global Metagenomic Sequencing Market report offers the important data related to the global Metagenomic Sequencing Market along with dominant players in the market. It highlights the information about the industries and market, technologies, and abilities over the trends and